These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3188970)

  • 1. Prolactin secretion in polycystic ovary syndrome: circadian rhythmicity and dynamic aspects.
    Ferrari E; Bossolo PA; Foppa S; Dalzano M; Comis S; Morelli MP; Peveri V; Mengozzi A
    Gynecol Endocrinol; 1988 Jun; 2(2):101-11. PubMed ID: 3188970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin secretion in polycystic ovary syndrome (PCOS).
    Szosland K; Pawlowicz P; Lewiński A
    Neuro Endocrinol Lett; 2015; 36(1):53-8. PubMed ID: 25789595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double blind controlled study of the hormonal and clinical effects of bromocriptine in the polycystic ovary syndrome.
    Buvat J; Buvat-Herbaut M; Marcolin G; Racadot A; Fourlinnie JC; Beuscart R; Fossati P
    J Clin Endocrinol Metab; 1986 Jul; 63(1):119-24. PubMed ID: 3519644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome.
    Prelević GM; Würzburger MI; Perić LA
    J Endocrinol Invest; 1987 Aug; 10(4):389-95. PubMed ID: 3119696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The gonadotropin, prolactin and sex steroid content of the blood from the inferior cavernous sinuses and the adrenal and ovarian veins of women with Itsenko-Cushing disease].
    Manusharova RA; Komissarenko IV; Iugrinov OG
    Vrach Delo; 1991 Mar; (3):71-4. PubMed ID: 2042357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic ovary syndrome and hyperprolactinemia are distinct entities.
    Filho RB; Domingues L; Naves L; Ferraz E; Alves A; Casulari LA
    Gynecol Endocrinol; 2007 May; 23(5):267-72. PubMed ID: 17558684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daytime decrease of prolactin levels is associated with PCOS regardless to nutritional status and other hormones levels.
    Franik G; Madej P; Guz-Lem M; Owczarek A; Chudek J; Olszanecka-Glinianowicz M
    Gynecol Endocrinol; 2017 May; 33(5):336-341. PubMed ID: 28277129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The acute effects of a dopamine antagonist (domperidone) on luteinising hormone, follicule stimulating hormone, prolactin and thyrotrophin secretion in polycystic ovarian syndrome: differential effect of ovulation.
    Murdoch AP; Dunlop W; Kendall-Taylor P; Watson MJ
    Clin Endocrinol (Oxf); 1984 Dec; 21(6):611-9. PubMed ID: 6439439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of prolactin in predicting prolactinοma in hyperprolactinaemic polycystic ovarian syndrome.
    Kyritsi EM; Dimitriadis GK; Angelousi A; Mehta H; Shad A; Mytilinaiou M; Kaltsas G; Randeva HS
    Eur J Clin Invest; 2018 Jul; 48(7):e12961. PubMed ID: 29845629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin levels in the polycystic ovary syndrome.
    Milewicz A
    J Reprod Med; 1984 Mar; 29(3):193-6. PubMed ID: 6233421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the association of vitamin D deficiency with gonadotropins and sex hormone in obese and non-obese women with polycystic ovary syndrome.
    Velija-Ašimi Z
    Med Glas (Zenica); 2014 Feb; 11(1):170-6. PubMed ID: 24496360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of prolactin secretion in polycystic ovary syndrome.
    Murdoch AP; Dunlop W; Kendall-Taylor P
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):165-75. PubMed ID: 3085993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J; Bergh T; Gennarelli G; Wide L
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evening not morning plasma cortisol level is higher in women with polycystic ovary syndrome.
    Kiałka M; Ociepka A; Milewicz T; Krzyczkowska-Sendrakowska M; Gosztyła K; Stochmal E; Lurzyńska M; Bałajewicz-Nowak M
    Przegl Lek; 2015; 72(5):240-2. PubMed ID: 26817325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of altered dopaminergic modulation of prolactin and thyrotropin secretion in patients with polycystic ovary syndrome.
    Velardo A; Pantaleoni M; Zironi C; Zizzo G; Marrama P
    Horm Res; 1991; 35(1):4-7. PubMed ID: 1916652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polycystic ovary: old concepts, new perspectives].
    Herrera Pombo JL
    Rev Clin Esp; 1989 Dec; 185(9):433-5. PubMed ID: 2696005
    [No Abstract]   [Full Text] [Related]  

  • 17. [Polycystic ovary syndrome associated with remarkable hyperprolactinemia--case report].
    Owecki M; Sowiński J
    Pol Merkur Lekarski; 2004 Oct; 17(100):385-7. PubMed ID: 15690710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin release in polycystic ovary.
    Falaschi P; del Pozo E; Rocco A; Toscano V; Petrangeli E; Pompei P; Frajese G
    Obstet Gynecol; 1980 May; 55(5):579-82. PubMed ID: 6768043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hyperprolactinemic polycystic ovary syndrome may not be an distinct entity.
    Corenblum B; Taylor PJ
    Fertil Steril; 1982 Nov; 38(5):549-52. PubMed ID: 6813147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. To what extent does polycystic ovary syndrome influence the cut-off value of prolactin? Findings of a community-based study.
    Mahboobifard F; Rahmati M; Amiri M; Azizi F; Ramezani Tehrani F
    Adv Med Sci; 2022 Mar; 67(1):79-86. PubMed ID: 34998115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.